Houlihan Lokey Advises Vet's Best Friend

Houlihan Lokey is pleased to announce that Vet’s Best Friend (VBF), a portfolio company of Lorient Capital and Revelstoke Capital Partners, has been acquired by Rarebreed Veterinary Partners (Rarebreed), a portfolio company of Revelstoke Capital Partners. The transaction closed on June 29, 2022.

Founded in 2019 by Jeff Wilson as an executive partnership with Lorient Capital, Vet's Best Friend is a leading veterinary practice management platform with 47 affiliated veterinary hospitals from Maine to Florida. The company is differentiated by its mission-oriented culture focused on “taking care of the people who take care of our pets.”

Rarebreed is a leading veterinary practice management platform with 71 affiliated veterinary practices. Rarebreed prides itself on building lasting relationships with its partner hospitals, with goals to provide top-notch patient care, world-class client service, and an unparalleled work experience.

Lorient Capital is a private investment firm focused exclusively on the healthcare industry, whose distinctive approach blends roots as entrepreneurs, operators, and investment professionals to build market-leading healthcare services and technology companies.

Founded in 2013 and based in Denver, Revelstoke is a private equity firm focused on building industry-leading companies in the healthcare services and healthcare technology sectors. Revelstoke currently has approximately $4.8 billion of assets under management and has completed 157 acquisitions since its inception.

Houlihan Lokey served as exclusive financial advisor to VBF. This transaction further strengthens and highlights Houlihan Lokey’s continued leadership position in multisite healthcare M&A and the veterinary sector.

Houlihan Lokey’s Healthcare Group is among the largest dedicated healthcare investment banking groups in the world. In 2021, the group closed 43 transactions and was ranked by Refinitiv as the No. 1 M&A advisor globally for healthcare transactions under $1 billion.* Houlihan Lokey’s Healthcare Group also advised on four closed transactions in the veterinary sector in 2021, making it one of the most active advisors in the sector.